Invention Grant
- Patent Title: Beta-hydroxyketones as topical active ingredients for the prevention or treatment of photodermatoses
-
Application No.: US15778747Application Date: 2016-11-02
-
Publication No.: US10660867B2Publication Date: 2020-05-26
- Inventor: Christophe Carola , Lilia Heider , Marina Lefort , Hansjuergen Driller
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano and Branigan, P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1ed9705
- International Application: PCT/EP2016/001815 WO 20161102
- International Announcement: WO2017/088950 WO 20170601
- Main IPC: A61K31/12
- IPC: A61K31/12 ; A61P17/00
Abstract:
The present invention relates to specific β-hydroxyketones of the formula (I) for use in the prevention and/or treatment of photodermatoses and to the use of specific β-hydroxyketones of the formula (I) as active ingredient in typical compositions for the prevention and/or non-therapeutic treatment of photodermatoses, in particular of polymorphic light eruption.
Public/Granted literature
- US20180353442A1 Beta-Hydroxyketones as topical active ingredients for the prevention or treatment of photodermatoses Public/Granted day:2018-12-13
Information query
